Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease
Screening and monitoring for cardiotoxicity during cancer treatment
Publication
, Chapter
Khouri, MG; Klem, I; Shenoy, C; Sulpher, J; Dent, SF
April 11, 2017
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Khouri, M. G., Klem, I., Shenoy, C., Sulpher, J., & Dent, S. F. (2017). Screening and monitoring for cardiotoxicity during cancer treatment. In Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease (pp. 43–80). https://doi.org/10.1007/978-3-319-43096-6_3
Khouri, M. G., I. Klem, C. Shenoy, J. Sulpher, and S. F. Dent. “Screening and monitoring for cardiotoxicity during cancer treatment.” In Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease, 43–80, 2017. https://doi.org/10.1007/978-3-319-43096-6_3.
Khouri MG, Klem I, Shenoy C, Sulpher J, Dent SF. Screening and monitoring for cardiotoxicity during cancer treatment. In: Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease. 2017. p. 43–80.
Khouri, M. G., et al. “Screening and monitoring for cardiotoxicity during cancer treatment.” Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease, 2017, pp. 43–80. Scopus, doi:10.1007/978-3-319-43096-6_3.
Khouri MG, Klem I, Shenoy C, Sulpher J, Dent SF. Screening and monitoring for cardiotoxicity during cancer treatment. Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease. 2017. p. 43–80.